Anti-Inflammatory Diet Tailored for People With Active Crohn's Disease
Tests a tailored anti-inflammatory diet in people with active Crohn's disease.
Plain-language title generated from the registry record
Registry title: Tailored Anti-Inflammatory American Diet for Patients With Crohn's Disease
Key facts
- Where
- Miami, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 16 and 75 years old?
Source: NCT07671872, who can take part
Where in United States
- University of MiamiMiami, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Miami
- Trial code
- NCT07671872
- Record updated
- 24 September 2026
- Original description
The purpose of this study is to test the effect of an anti-inflammatory diet tailored for patients living in the United States with Crohn's Disease (CD) on clinical symptoms and disease inflammation and to identify biomarkers of response to dietary therapy.Read full original descriptionShow less
Targeting Gut Inflammation Through Diet: a Tailored American Diet for Patients With Crohn's Disease
The purpose of this study is to test the effect of an anti-inflammatory diet tailored for patients living in the United States with Crohn's Disease (CD) on clinical symptoms and disease inflammation and to identify biomarkers of response to dietary therapy.
Inclusion: Documented diagnosis with Crohn's Disease from medical records; Ages 16-75; Mild to moderately active CD disease, defined by one of the following criteria:; Crohn's disease activity index (CDAI) 150-250 (mild-to-moderate only active disease) AND presence of active inflammation either by: fecal calprotectin >150mg/dl. or radiologic findings of active ileal and/or colonic disease, or endoscopic findings showing active ileal and/or colonic disease within 4 weeks of baseline; -On stable medications for their disease as or 3 months if medication is not listed.
Exclusion: Prior J pouch or diversion; Crohn's specific complicated disease including active Stenotic (stricturing, B2) disease within the past 12 months, or Internal penetrating (B3) disease, or Draining perianal fistula, or Prior bowel resection; Patients with concomitant Celiac disease; Recent inflammatory bowel disease (IBD) related hospitalizations in the last 4 weeks; Clostridium difficile or enteric infections in the last 4 weeks; Active cancer or conditions limiting their ability to follow a diet (heart failure, end stage renal disease); Ages < 16 and > 75 years old; Diagnosis of Ulcerative Colitis (UC); Use of probiotics in the last 4 weeks; Patients following the specific carbohydrate diet or Mediterranean diet or anti-inflammatory diet; Pregnancy, breastfeeding or planning to become pregnant during study period; Use of Total Parenteral Nutrition at the time of screening and during the study period; Other significant or life-threatening co-morbidities; The need for antibiotic use during the study period; Adults unable to consent; Prisoners.